Assembly Biosciences, Inc. - Common Stock — 재무제표 (NASDAQ:ASMB) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 283.25 M191.06 M101.79 M136.82 M119.17 M257.59 M 총 부채 42.68 M22.13 M19.13 M95.73 M85.81 M50.84 M 자본금 총액 240.58 M168.93 M82.66 M41.1 M33.36 M206.75 M 총 부채 및 주주자본 283.25 M191.06 M101.79 M136.82 M119.17 M257.59 M 총부채 —————— 순부채 ——————

뉴스

Assembly Biosciences, Inc. (ASMB) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates

Assembly Biosciences, Inc. (ASMB) Presents at ESCMID Global 2026 - Slideshow (NASDAQ:ASMB) 2026-04-25

Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB)

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Assembly Biosciences (NASDAQ:ASMB), Gilead Sciences (NASDAQ:GILD)

Gilead exercises option for Assembly Bio’s herpes treatment programs

제퍼리스, HSV 데이터에 힘입어 어셈블리 바이오사이언스 목표 주가 62달러로 상향 조정